Buy Like Buffett
Watchlist

Flagship explainer

What drives Elite Pharmaceuticals, Inc.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity59%Tax burden79%net income ÷ pretax incomeInterest burden116%pretax ÷ operating incomeOperating margin33%operating income ÷ revenueAsset turnover1.27×revenue ÷ average assetsEquity multiplier1.54×average assets ÷ average equityAs of 2026-03-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$44.9MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
Income before tax$56.8MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
Operating income$49.1MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
$149MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
Ending assets$138MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
Beginning assets$96.4MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
$98.9MFY2026
  • 10-K · FY 2026Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
$53.5MFY2025
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-031070 · filed Jun 29, 2026
Source: · event Mar 31, 2026 · retrieved Oct 15, 2026 · annual-row source set
Embed this chart

View the full Elite Pharmaceuticals, Inc. analysis at Buy Like Buffett

ELTP dupont explainer — Buy Like Buffett · Buy Like Buffett